Wood Tarver Financial Group’s AbbVie ABBV Stock Holding History

Wood Tarver Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$403K	Sell	1,602 -18	-1%	-$3.87K	0.1%	111
2026 Q1	$352K	Buy	1,620 +35	+2%	+$7.76K	0.1%	116
2025 Q4	$362K	Hold	1,585	–	–	0.1%	115
2025 Q3	$366K	Hold	1,585	–	–	0.11%	112
2025 Q2	$294K	Hold	1,585	–	–	0.09%	119
2025 Q1	$332K	Hold	1,585	–	–	0.11%	100
2024 Q4	$281K	Buy	+1,585	New	+$291K	0.09%	112

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wood Tarver Financial Group's ABBV Position: Q2 2026 in Review

Wood Tarver Financial Group reduced its AbbVie (ABBV) stake by 1.1% in Q2 2026, selling an estimated $3.87K and leaving 1,602 shares worth $403K. The position accounts for 0.1% of the portfolio, ranked #111.

Wood Tarver Financial Group first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Wood Tarver Financial Group held 1,602 shares of AbbVie worth $403K as of Q2 2026.
Wood Tarver Financial Group sold 18 AbbVie shares in Q2 2026, an estimated $3.87K.
AbbVie made up 0.1% of Wood Tarver Financial Group's portfolio in Q2 2026, its #111 holding.
Wood Tarver Financial Group first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wood Tarver Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.